# DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

> **NCT00004866** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo**

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** exatecan mesylate

## Key facts

- **NCT ID:** NCT00004866
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004866, "DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00004866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*